Market Briefs

Headlines

HIMS
Hims & Hers stock chart drops with Wegovy copycat legal battle and revenue growth highlights

Hims & Hers Plunges on Wegovy Copycat Fallout

Hims & Hers shares tumble amid legal battles over Wegovy copycat, despite strong revenue growth.

February 9, 2026

4 min read

Hims–Novo Nordisk clash over new weight-loss pill

Hims & Hers faces legal heat from Novo Nordisk over its low-cost weight-loss pill launch.

Feb 7, 2026

3 min read

Hims jolts weight‑loss drug market with $49 Wegovy pill

Hims disrupts weight-loss market with $49 Wegovy pill, pressuring Novo Nordisk and Eli Lilly shares.

Feb 5, 2026

4 min read